European Hospital | AutoEvaLUP | Lupus | e-cohort and SNDS

The AutoEvaLUP study focuses on adult patients suffering from systemic lupus erythematosus (fatigue, pain, anxiety, depression). The primary objective of the study is to evaluate the predictive performance of flare occurrence through monthly longitudinal assessment of fatigue using self-questionnaires. Patient self-reports will be confirmed by analyzing therapeutic modification data from the French National Health Data System (SNDS).

Study start: Q3 2023

Study end: Q3 2025

Role of Alsinova: Implementation of the secure patient platform, management of deterministic matching with the SNDS, and support for regulatory submissions (ethics committee and CNIL).